The role of corticosteroids in patients hospitalized for COVID-19 at Mexico general Hospital
Copyright: © 2023 Permanyer..
OBJECTIVE: To compare the evolution of hospitalized patients infected with SARS-CoV-2 who received corticosteroid-based treatment versus patients who received standard therapy.
METHOD: Retrospective, observational, and analytical study. Clinical records were collected from the different intensive care units, and data were obtained from confirmed COVID-19 patients over 18 years of age who were hospitalized. The population was divided into two groups: patients who received corticosteroid treatment, and those who received standard therapy.
RESULTS: A total of 1603 patients were admitted to hospital, and of these 984 (62.9%) were discharged due to death. The main result was the identification by odds ratio (OR: 4.68; 95% confidence interval [95% CI]: 3.75-5.83; p = 0.001) as risk for death to the use of systemic steroids, as well as the use of invasive mechanical ventilation (OR: 2.26; 95% CI: 1.80-2.82; p < 0.001). The male gender was the most affected with 1051 (65.6%) patients. Mean age was 56 years (± 14).
CONCLUSIONS: Corticosteroid use was associated with poor prognosis in patients hospitalized for COVID-19 compared to those receiving standard therapy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:91 |
---|---|
Enthalten in: |
Cirugia y cirujanos - 91(2023), 2 vom: 01., Seite 233-239 |
Sprache: |
Englisch |
---|
Weiterer Titel: |
El papel de los corticoesteroides en pacientes hospitalizados por COVID-19 en el Hospital General de México |
---|
Beteiligte Personen: |
Iturbide-Mauricio, Leonel [VerfasserIn] |
---|
Links: |
---|
Themen: |
Acute respiratory failure |
---|
Anmerkungen: |
Date Completed 25.04.2023 Date Revised 25.04.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.24875/CIRU.22000233 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM355880547 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM355880547 | ||
003 | DE-627 | ||
005 | 20231226065301.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.24875/CIRU.22000233 |2 doi | |
028 | 5 | 2 | |a pubmed24n1186.xml |
035 | |a (DE-627)NLM355880547 | ||
035 | |a (NLM)37084296 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Iturbide-Mauricio, Leonel |e verfasserin |4 aut | |
245 | 1 | 4 | |a The role of corticosteroids in patients hospitalized for COVID-19 at Mexico general Hospital |
246 | 3 | 3 | |a El papel de los corticoesteroides en pacientes hospitalizados por COVID-19 en el Hospital General de México |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.04.2023 | ||
500 | |a Date Revised 25.04.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright: © 2023 Permanyer. | ||
520 | |a OBJECTIVE: To compare the evolution of hospitalized patients infected with SARS-CoV-2 who received corticosteroid-based treatment versus patients who received standard therapy | ||
520 | |a METHOD: Retrospective, observational, and analytical study. Clinical records were collected from the different intensive care units, and data were obtained from confirmed COVID-19 patients over 18 years of age who were hospitalized. The population was divided into two groups: patients who received corticosteroid treatment, and those who received standard therapy | ||
520 | |a RESULTS: A total of 1603 patients were admitted to hospital, and of these 984 (62.9%) were discharged due to death. The main result was the identification by odds ratio (OR: 4.68; 95% confidence interval [95% CI]: 3.75-5.83; p = 0.001) as risk for death to the use of systemic steroids, as well as the use of invasive mechanical ventilation (OR: 2.26; 95% CI: 1.80-2.82; p < 0.001). The male gender was the most affected with 1051 (65.6%) patients. Mean age was 56 years (± 14) | ||
520 | |a CONCLUSIONS: Corticosteroid use was associated with poor prognosis in patients hospitalized for COVID-19 compared to those receiving standard therapy | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Observational Study | |
650 | 4 | |a Acute respiratory failure | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Corticoesteroides | |
650 | 4 | |a Corticosteroids | |
650 | 4 | |a Insuficiencia respiratoria aguda | |
650 | 4 | |a Mortalidad | |
650 | 4 | |a Mortality | |
650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
700 | 1 | |a Palacios-Vaca, Jessica |e verfasserin |4 aut | |
700 | 1 | |a Calleja-López, Jesús R |e verfasserin |4 aut | |
700 | 1 | |a Pérez-Navarro, Monserrat |e verfasserin |4 aut | |
700 | 1 | |a García-García, José A |e verfasserin |4 aut | |
700 | 1 | |a Espinosa-García, Ana M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cirugia y cirujanos |d 1945 |g 91(2023), 2 vom: 01., Seite 233-239 |w (DE-627)NLM041624114 |x 2444-054X |7 nnns |
773 | 1 | 8 | |g volume:91 |g year:2023 |g number:2 |g day:01 |g pages:233-239 |
856 | 4 | 0 | |u http://dx.doi.org/10.24875/CIRU.22000233 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 91 |j 2023 |e 2 |b 01 |h 233-239 |